| ||||||||||
| Rating | Health Concerns |
|---|---|
![]() |
|
Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary
studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but
minimal or no scientific evidence. For a supplement, little scientific support and/or minimal
health benefit. | |
Since it is not an essential nutrient, HCA is not associated with a deficiency state.
Optimal amounts of HCA remain unknown. Although dieters sometimes take 500 mg of HCA three times per day (before each meal), this amount is far below the levels used in animal research (figured on a per-pound body weight basis). The effect of HCA is enhanced when used in conjunction with a low-fat diet, because HCA does nothing to reduce the caloric effects of dietary fat. Since HCA’s mechanism of action seems to be at least partially a blockade of conversion of simple sugars into fats,13 it is likely to work best in conjunction with a high simple sugar diet. HCA may therefore be less useful if it only offsets the negative effects of an otherwise unhealthy diet. High-fibre diets may impair absorption of HCA as noted above. HCA supplements are available in many forms, including tablets, capsules, powders, snack bars, and chewing gum.
HCA has not been linked to any adverse effects.
At the time of writing, there were no well-known drug interactions with Hydroxycitric Acid.
1. Lowenstein JM. Effect of (-)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. J Biol Chem 1971;246:629–32.
2. Triscari J, Sullivan AC. Comparative effects of (-)-hydroxycitrate and (-)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in vivo. Lipids 1977;12:357–63.
3. Cheema-Dhadli S, Harlperin ML, Leznoff CC. Inhibition of enzymes which interact with citrate by (-)hydroxycitrate and 1,2,3,-tricarboxybenzene. Eur J Biochem 1973;38:98–102.
4. Sullivan AC, Hamilton JG, Miller ON, et al. Inhibition of lipogenesis in rat liver by (-)-hydroxycitrate. Arch Biochem Biophys 1972;150:183–90.
5. Greenwood MRC, Cleary MP, Gruen R, et al. Effect of (-)-hydroxycitrate on development of obesity in the Zucker obese rat. Am J Physiol 1981;240:E72–8.
6. Sullivan AC, Triscari J. Metabolic regulation as a control for lipid disorders. Am J Clin Nutr 1977;30:767–76.
7. Sullivan AC, Triscari J, Hamilton JG, et al. Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. I. Lipogenesis. Lipids 1974;9:121–8.
8. Sullivan AC, Triscari J, Hamilton JG, et al. Effect of (-)-hydroxycitrate upon the accumulation of lipid in the rat. II. Appetite. Lipids 1974;9:129–34.
9. Sergio W. A natural food, Malabar Tamarind, may be effective in the treatment of obesity. Med Hypotheses 1988;27:39–40.
10. Heymsfield SB, Allison DB, Vasselli JR, et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent. JAMA 1998;280:1596–600.
11. Seroy S. Response to JAMA HCA report. Townsend Letter for Doctors and Patients Feb/Mar 1999:120–1 [letter/review].
12. Badmaev V, Majeed M, Conte AA. Garcinia cambogia for weight loss. JAMA 1999;282:233–4 [letter].
13. Lowenstein JM. Experiments with (-)hydroxycitrate. In: Burtley W, Kornberg HL, Quayle JR, eds. Essays in Cell Metabolism. New York: Wiley Interscience, 1970, 153–66.
| |||||||